Mouse model of metformin-induced diarrhea. Issue 1 (25th March 2020)
- Record Type:
- Journal Article
- Title:
- Mouse model of metformin-induced diarrhea. Issue 1 (25th March 2020)
- Main Title:
- Mouse model of metformin-induced diarrhea
- Authors:
- Takemori, Hiroshi
Hamamoto, Akie
Isogawa, Kenta
Ito, Masafumi
Takagi, Masanori
Morino, Hirofumi
Miura, Takanori
Oshida, Kyoichi
Shibata, Takashi - Abstract:
- Abstract : Objective: Metformin, an oral medication used for type 2 diabetes mellitus, is the most commonly prescribed drug with less economic burden of patients. Although metformin's efficacy and safety have long been recognized, approximately 5% of the patients treated with this drug develop severe diarrhea as an adverse effect and have to abandon treatment. Because there is no animal model to study metformin-induced diarrhea, it is hard to develop methods to maintain quality of life of patients prescribed with metformin. Research design and methods: Using mouse models, we tried to develop an evaluation system for metformin-induced diarrhea to improve diarrheal symptoms in patients with diabetes. Healthy (C57BL/6J) and diabetic obese ( db/db ) mice were subjected to a stepwise dose escalation of metformin (250 mg/kg/day (125 mg/kg twice daily oral dose)—1000 mg/kg/day (500 mg/kg twice daily oral dose)), and fecal moisture contents and their score were monitored. To evaluate anti-diarrheal medications, wood creosote (a traditional medicine) was tested. Several groups of enterobacteria in fresh feces were examined by using PCR. Results: 1000 mg/kg/day (four times maximal effective dose) of metformin significantly increased fecal moisture content. Although no symptoms of diarrhea were observed in healthy C57BL/6J mice, the same dose of metformin induced severe diarrhea in diabetic obese db/db mice. A reduction in PCR signals for the Firmicutes group was associated withAbstract : Objective: Metformin, an oral medication used for type 2 diabetes mellitus, is the most commonly prescribed drug with less economic burden of patients. Although metformin's efficacy and safety have long been recognized, approximately 5% of the patients treated with this drug develop severe diarrhea as an adverse effect and have to abandon treatment. Because there is no animal model to study metformin-induced diarrhea, it is hard to develop methods to maintain quality of life of patients prescribed with metformin. Research design and methods: Using mouse models, we tried to develop an evaluation system for metformin-induced diarrhea to improve diarrheal symptoms in patients with diabetes. Healthy (C57BL/6J) and diabetic obese ( db/db ) mice were subjected to a stepwise dose escalation of metformin (250 mg/kg/day (125 mg/kg twice daily oral dose)—1000 mg/kg/day (500 mg/kg twice daily oral dose)), and fecal moisture contents and their score were monitored. To evaluate anti-diarrheal medications, wood creosote (a traditional medicine) was tested. Several groups of enterobacteria in fresh feces were examined by using PCR. Results: 1000 mg/kg/day (four times maximal effective dose) of metformin significantly increased fecal moisture content. Although no symptoms of diarrhea were observed in healthy C57BL/6J mice, the same dose of metformin induced severe diarrhea in diabetic obese db/db mice. A reduction in PCR signals for the Firmicutes group was associated with metformin-induced diarrhea. Wood creosote reduced diarrhea (high water-content) without affecting metformin's efficacy or enterobacterial flora levels. Conclusions: We have created the first animal model of metformin-induced diarrhea using db/db mice, which will provide better quality of life for patients suffering from diarrhea caused by metformin. … (more)
- Is Part Of:
- BMJ open diabetes research and care. Volume 8:Issue 1(2020)
- Journal:
- BMJ open diabetes research and care
- Issue:
- Volume 8:Issue 1(2020)
- Issue Display:
- Volume 8, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 8
- Issue:
- 1
- Issue Sort Value:
- 2020-0008-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-03-25
- Subjects:
- metformin -- diarrhea -- mouse model(s) -- oral antidiabetics
Diabetes -- Periodicals
616.462005 - Journal URLs:
- http://www.bmj.com/archive ↗
http://drc.bmj.com/ ↗ - DOI:
- 10.1136/bmjdrc-2019-000898 ↗
- Languages:
- English
- ISSNs:
- 2052-4897
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17068.xml